BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Liabilities (Quarterly) : 5.402B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.402B |
| March 31, 2026 | 2.379B |
| December 31, 2025 | 1.507B |
| September 30, 2025 | 1.558B |
| June 30, 2025 | 1.429B |
| March 31, 2025 | 1.354B |
| December 31, 2024 | 1.331B |
| September 30, 2024 | 1.438B |
| June 30, 2024 | 1.781B |
| March 31, 2024 | 1.799B |
| December 31, 2023 | 1.890B |
| September 30, 2023 | 1.861B |
| June 30, 2023 | 1.780B |
| March 31, 2023 | 1.775B |
| December 31, 2022 | 1.772B |
| September 30, 2022 | 1.696B |
| June 30, 2022 | 1.641B |
| March 31, 2022 | 1.671B |
| December 31, 2021 | 1.733B |
| September 30, 2021 | 1.711B |
| June 30, 2021 | 1.657B |
| March 31, 2021 | 1.643B |
| December 31, 2020 | 1.742B |
| September 30, 2020 | 2.104B |
| June 30, 2020 | 2.065B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.483B |
| December 31, 2019 | 1.568B |
| September 30, 2019 | 1.484B |
| June 30, 2019 | 1.432B |
| March 31, 2019 | 1.499B |
| December 31, 2018 | 1.521B |
| September 30, 2018 | 1.780B |
| June 30, 2018 | 1.740B |
| March 31, 2018 | 1.790B |
| December 31, 2017 | 1.869B |
| September 30, 2017 | 1.767B |
| June 30, 2017 | 1.224B |
| March 31, 2017 | 1.170B |
| December 31, 2016 | 1.257B |
| September 30, 2016 | 1.196B |
| June 30, 2016 | 1.170B |
| March 31, 2016 | 1.377B |
| December 31, 2015 | 1.329B |
| September 30, 2015 | 1.332B |
| June 30, 2015 | 1.292B |
| March 31, 2015 | 1.233B |
| December 31, 2014 | 962.56M |
| September 30, 2014 | 931.99M |
| June 30, 2014 | 883.72M |
| March 31, 2014 | 880.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| Ionis Pharmaceuticals, Inc. | 2.555B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.72B |
| Shareholders Equity (Quarterly) | 6.322B |
| Debt to Equity Ratio | 0.6672 |
| Current Ratio | 2.387 |
| Net Debt Paydown Yield | -6.52% |